ISSN 0017-8748 doi: 10.1111/head.12519 Published by Wiley Periodicals, Inc.
Headache © 2015 American Headache Society
From the Editorial Office Senior editors Daroff, Robert Dr. Daroff has nothing to disclose.
The associate editors of Headache, individuals who play a pivotal role in advising the editor-in-chief on the publication worthiness of a submission, are committed to ensuring that the journal’s review process is transparent. In support of that objective, Headache will publish an annual declaration of all conflicts of interest for members of the board for the previous 12 months. Headache aims to be compliant with the International Committee of Medical Journal Editors (ICMJE) statement encouraging all journals to publish any potential conflicts within the editorial review process.
Ducros, Anne Dr. Ducros receives consulting fees and/or honoraria from Amgen. Ferrari, Michel Dr. Ferrari has nothing to disclose. Goadsby, Peter Dr. Goadsby has received consulting fees and/or honoraria from Pfizer, Zogenix, Nevrocorp, Impax, Dr. Reddy, Zosano, and Amgen. He is on the speaker’s bureau of Allergan, Inc., and Pfizer, Inc. He has received other financial benefit as an expert witness from for Journal Watch Neurology (manuscript preparation) Medico (legal advice, patient advice). Dr. Goadsby’s institution has received grants from ENeura, Amgen, and Allergan.
FROM THE ICMJE UNIFORM REQUIREMENTS II.D.3. Potential Conflicts of Interest Related to Commitments of Editors, Journal Staff, or Reviewers.—“Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and disqualify themselves from any decisions where they have a conflict of interest. Editorial staff must not use the information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff.” The Headache Editorial Board members were requested to provide their conflicts of interest during the past year using the standard American Headache Society disclosure form.
Rothrock, John Dr. Rothrock receives consulting fees and/or honoraria from Allergan, Inc. He is on the speaker’s bureau of Allergan, Inc. Dr. Rothrock has an equity interest in Vivus and Zogenix. He is the recipient of research grants from Allergan, Inc., Amgen, GlaxoSmithKline, and Teva. Associate editors Aurora, Sheena Dr. Aurora has received consulting fees and/or honoraria from Merck, Nupathe, eNeura, and Allergan, Inc. Dr. Aurora is also on all of their speaker’s bureaus. Burch, Rebecca Dr. Burch has nothing to disclose. Cady, Roger Dr. Cady has received consulting fees and/or honoraria from Allergan, Inc., Amgen, Avanir, Boston Scientific, Evidera, MAP Pharmaceuticals, Merck & Co., Inc.,
Editor-in-chief Ward, Thomas Dr. Ward has received consulting fees and/or honoraria from Cowan & Co. 211
212 Nautilus Neurosciences, Novartis, NuPathe, Optinose, Pfizer, Inc., Primary Care Education, Transcept, and Zogenix. He is on the speaker’s bureau of Allergan, Inc., Impax Pharmaceuticals, Merck & Co., Inc., Nautilus Neuroscience, Novartis, and Zogenix. Dr. Cady is a recipient of research grants from Allergan, Inc., Tian Medical, Fortis Spectrum, GlaxoSmithKline, PuraMed Biosciences, and Nico Worldwide. Friedman, Deborah Dr. Friedman is on the speaker’s bureau of Allergan. She has received consulting fees and/or honoraria from Neurology Reviews and MedLink Neurology. Dr. Friedman is a recipient of a research grant from National Eye Institute. Dr. Friedman is a recipient of research grants from Merck & Co., Inc., and ElectroCore (in which funds were paid to her institution). She was also an expert witness (for the plaintiff and defense) for idiopathic intracranial hypertension. Griffiths, Lyn Dr. Griffiths has nothing to disclose. Hershey, Andrew Dr. Hershey has received consulting fees and/or honoraria from Allergan, Inc. Kaniecki, Robert Dr. Kaniecki has nothing to disclose. Krymchantowski, Abouch Dr. Krymchantowski has nothing to disclose. Levy, Dan Dr. Levy has nothing to disclose. Loder, Elizabeth Dr. Loder is an officer, director, or holds a fiduciary role in the Headache Cooperative of New England. Martin, Vincent Dr. Martin has received consulting fees and/or honoraria from Allergan, Inc., eNeura Therapeutics, GlaxoSmithKline, Johnson and Johnson, Nautilus Neurosciences, Novartis, Nupath, Vedanta Research, and Zogenix. He is on the speaker’s bureau of Allergan, Inc. Dr. Martin has an equity interest in/or stock options in eNeura Therapeutics. He is the recipient of research grants from the National Headache Foundation, Novartis, and Vedanta Research.
February 2015 McGeeney, Brian Dr. McGeeney has received consulting fees and/or honoraria Allergan, Inc., and Insys Pharmaceuticals. He has equity interests and/or stock options in Pfizer, Inc. Dr. McGeeney holds an officer, director, or other fiduciary role with the Headache Cooperative of New England. Levin, Morris Dr. Levin has received consulting fees and/or honoraria from Allergan, Inc., Supernus, Transept, and Nupathe. Dr. Levin has also received royalty income from Oxford University Press and Anadem Publishing. Pascual, Julio Dr. Pascual has received consulting fees and/or honoraria from Allergan, Inc. Penzien, Donald Dr. Penzien is the recipient of research grants from Merck & Co., Inc. Peterlin, B. Lee Dr. Peterlin has received research grants from Luitpold Pharmaceuticals, GlaxoSmithKline, NIH/ NINDS, Landenbergr Foundation. Dr. Peterlin also receives a salary from the NIH/NINDS. Queiroz, Luiz P. Dr. Queiroz is on the speaker’s bureau of Libbs Farmaceutica. Rains, Jeanetta Dr. Rains has received consulting fees and/or honoraria from the NIH. Rizzoli, Paul Dr. Rizzoli receives consulting fees and/or honoraria from Heptares. Schwedt, Todd Dr. Schwedt has received consulting fees and/or honoraria from Allergan, Inc., Supernus, and Zogenix. He has received royalty income from UpToDate. Smitherman, Todd Dr. Smitherman is the recipient of a research grant from Merck and Co., Inc. Sprenger, Till Dr. Sprenger receives consulting fees and/or honoraria from ElectroCore and Novartis. He is the recipient of
Headache
213
research grants from Novartis and is on the speaker’s bureau for Novartis and Genzyme. Swanson, Jerry Dr. Swanson UpToDate.
receives
royalty
income
from
Tepper, Deborah Dr. Deborah Tepper has nothing to disclose. Tepper, Stewart Dr. Stewart Tepper has received consulting fees and/or honoraria from ATI, Allergan, Inc., Amgen, Civitas, Depomed, ElectroCore, Impax, Labrys Biologics (now Teva), Nautilus Neurosciences (now Avanir), Merck, NuPathe (now Teva), Pfizer, and Zogenix. He is on the speaker’s bureau of ATI, Allergan, Inc., Depomed, and Impax. Dr. Tepper has stock options in ATI. He is the recipient of research grants from Amgen, Electrocore, GlaxoSmithKline, Labrys Biologics (now Teva), and NuPathe (now Teva). Tietjen, Gretchen Dr. Tietjen has nothing to disclose. Valenca, Marcelo Dr. Valenca has nothing to disclose.
Wang, Shuu-Jiun Dr. Wang receives consulting fees/honoraria from Allergan, Inc., Pfizer Taiwan, GSK Taiwan, and MSD Taiwan. Dr. Wang also is the recipient of research grants from Novartis Taiwan. Weeks, Randall Dr. Weeks receives consulting fees/honoraria for his role as Advisory Board member of Allergan, Inc., and Depomed. Statistics and Methodology Houle, Timothy Dr. Houle has received consulting fees and/or honoraria from Depomed. He is the recipient of research grants from Merck & Co., Inc. Turner, Dana Dr. Turner is the recipient of research grants from Merck, Inc. Jason Roberts, PhD Executive Editor, Headache
Copyright of Headache: The Journal of Head & Face Pain is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
Headache © 2015 American Headache Society
From the Editorial Office Senior editors Daroff, Robert Dr. Daroff has nothing to disclose.
The associate editors of Headache, individuals who play a pivotal role in advising the editor-in-chief on the publication worthiness of a submission, are committed to ensuring that the journal’s review process is transparent. In support of that objective, Headache will publish an annual declaration of all conflicts of interest for members of the board for the previous 12 months. Headache aims to be compliant with the International Committee of Medical Journal Editors (ICMJE) statement encouraging all journals to publish any potential conflicts within the editorial review process.
Ducros, Anne Dr. Ducros receives consulting fees and/or honoraria from Amgen. Ferrari, Michel Dr. Ferrari has nothing to disclose. Goadsby, Peter Dr. Goadsby has received consulting fees and/or honoraria from Pfizer, Zogenix, Nevrocorp, Impax, Dr. Reddy, Zosano, and Amgen. He is on the speaker’s bureau of Allergan, Inc., and Pfizer, Inc. He has received other financial benefit as an expert witness from for Journal Watch Neurology (manuscript preparation) Medico (legal advice, patient advice). Dr. Goadsby’s institution has received grants from ENeura, Amgen, and Allergan.
FROM THE ICMJE UNIFORM REQUIREMENTS II.D.3. Potential Conflicts of Interest Related to Commitments of Editors, Journal Staff, or Reviewers.—“Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and disqualify themselves from any decisions where they have a conflict of interest. Editorial staff must not use the information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff.” The Headache Editorial Board members were requested to provide their conflicts of interest during the past year using the standard American Headache Society disclosure form.
Rothrock, John Dr. Rothrock receives consulting fees and/or honoraria from Allergan, Inc. He is on the speaker’s bureau of Allergan, Inc. Dr. Rothrock has an equity interest in Vivus and Zogenix. He is the recipient of research grants from Allergan, Inc., Amgen, GlaxoSmithKline, and Teva. Associate editors Aurora, Sheena Dr. Aurora has received consulting fees and/or honoraria from Merck, Nupathe, eNeura, and Allergan, Inc. Dr. Aurora is also on all of their speaker’s bureaus. Burch, Rebecca Dr. Burch has nothing to disclose. Cady, Roger Dr. Cady has received consulting fees and/or honoraria from Allergan, Inc., Amgen, Avanir, Boston Scientific, Evidera, MAP Pharmaceuticals, Merck & Co., Inc.,
Editor-in-chief Ward, Thomas Dr. Ward has received consulting fees and/or honoraria from Cowan & Co. 211
212 Nautilus Neurosciences, Novartis, NuPathe, Optinose, Pfizer, Inc., Primary Care Education, Transcept, and Zogenix. He is on the speaker’s bureau of Allergan, Inc., Impax Pharmaceuticals, Merck & Co., Inc., Nautilus Neuroscience, Novartis, and Zogenix. Dr. Cady is a recipient of research grants from Allergan, Inc., Tian Medical, Fortis Spectrum, GlaxoSmithKline, PuraMed Biosciences, and Nico Worldwide. Friedman, Deborah Dr. Friedman is on the speaker’s bureau of Allergan. She has received consulting fees and/or honoraria from Neurology Reviews and MedLink Neurology. Dr. Friedman is a recipient of a research grant from National Eye Institute. Dr. Friedman is a recipient of research grants from Merck & Co., Inc., and ElectroCore (in which funds were paid to her institution). She was also an expert witness (for the plaintiff and defense) for idiopathic intracranial hypertension. Griffiths, Lyn Dr. Griffiths has nothing to disclose. Hershey, Andrew Dr. Hershey has received consulting fees and/or honoraria from Allergan, Inc. Kaniecki, Robert Dr. Kaniecki has nothing to disclose. Krymchantowski, Abouch Dr. Krymchantowski has nothing to disclose. Levy, Dan Dr. Levy has nothing to disclose. Loder, Elizabeth Dr. Loder is an officer, director, or holds a fiduciary role in the Headache Cooperative of New England. Martin, Vincent Dr. Martin has received consulting fees and/or honoraria from Allergan, Inc., eNeura Therapeutics, GlaxoSmithKline, Johnson and Johnson, Nautilus Neurosciences, Novartis, Nupath, Vedanta Research, and Zogenix. He is on the speaker’s bureau of Allergan, Inc. Dr. Martin has an equity interest in/or stock options in eNeura Therapeutics. He is the recipient of research grants from the National Headache Foundation, Novartis, and Vedanta Research.
February 2015 McGeeney, Brian Dr. McGeeney has received consulting fees and/or honoraria Allergan, Inc., and Insys Pharmaceuticals. He has equity interests and/or stock options in Pfizer, Inc. Dr. McGeeney holds an officer, director, or other fiduciary role with the Headache Cooperative of New England. Levin, Morris Dr. Levin has received consulting fees and/or honoraria from Allergan, Inc., Supernus, Transept, and Nupathe. Dr. Levin has also received royalty income from Oxford University Press and Anadem Publishing. Pascual, Julio Dr. Pascual has received consulting fees and/or honoraria from Allergan, Inc. Penzien, Donald Dr. Penzien is the recipient of research grants from Merck & Co., Inc. Peterlin, B. Lee Dr. Peterlin has received research grants from Luitpold Pharmaceuticals, GlaxoSmithKline, NIH/ NINDS, Landenbergr Foundation. Dr. Peterlin also receives a salary from the NIH/NINDS. Queiroz, Luiz P. Dr. Queiroz is on the speaker’s bureau of Libbs Farmaceutica. Rains, Jeanetta Dr. Rains has received consulting fees and/or honoraria from the NIH. Rizzoli, Paul Dr. Rizzoli receives consulting fees and/or honoraria from Heptares. Schwedt, Todd Dr. Schwedt has received consulting fees and/or honoraria from Allergan, Inc., Supernus, and Zogenix. He has received royalty income from UpToDate. Smitherman, Todd Dr. Smitherman is the recipient of a research grant from Merck and Co., Inc. Sprenger, Till Dr. Sprenger receives consulting fees and/or honoraria from ElectroCore and Novartis. He is the recipient of
Headache
213
research grants from Novartis and is on the speaker’s bureau for Novartis and Genzyme. Swanson, Jerry Dr. Swanson UpToDate.
receives
royalty
income
from
Tepper, Deborah Dr. Deborah Tepper has nothing to disclose. Tepper, Stewart Dr. Stewart Tepper has received consulting fees and/or honoraria from ATI, Allergan, Inc., Amgen, Civitas, Depomed, ElectroCore, Impax, Labrys Biologics (now Teva), Nautilus Neurosciences (now Avanir), Merck, NuPathe (now Teva), Pfizer, and Zogenix. He is on the speaker’s bureau of ATI, Allergan, Inc., Depomed, and Impax. Dr. Tepper has stock options in ATI. He is the recipient of research grants from Amgen, Electrocore, GlaxoSmithKline, Labrys Biologics (now Teva), and NuPathe (now Teva). Tietjen, Gretchen Dr. Tietjen has nothing to disclose. Valenca, Marcelo Dr. Valenca has nothing to disclose.
Wang, Shuu-Jiun Dr. Wang receives consulting fees/honoraria from Allergan, Inc., Pfizer Taiwan, GSK Taiwan, and MSD Taiwan. Dr. Wang also is the recipient of research grants from Novartis Taiwan. Weeks, Randall Dr. Weeks receives consulting fees/honoraria for his role as Advisory Board member of Allergan, Inc., and Depomed. Statistics and Methodology Houle, Timothy Dr. Houle has received consulting fees and/or honoraria from Depomed. He is the recipient of research grants from Merck & Co., Inc. Turner, Dana Dr. Turner is the recipient of research grants from Merck, Inc. Jason Roberts, PhD Executive Editor, Headache
Copyright of Headache: The Journal of Head & Face Pain is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
